Beyond Plasmids: How Synthetic DNA Could Advance Genetic Medicines

Listen now to a special Breakthrough episode of the Xtalks Life Science Podcast

Hear from 4basebio CEO Dr. Amy Walker on the potential of cell-free synthetic DNA to advance genetic medicine manufacturing.

As the development of genetic medicines accelerates, the demand for high-quality DNA starting materials continues to grow. However, traditional plasmid DNA production can introduce manufacturing complexities and quality challenges.

Could cell-free synthetic DNA offer an alternative?

In Episode 271 of the Xtalks Life Science Podcast, 4basebio CEO Dr. Amy Walker joins host Dr. Corey Stanton to discuss the evolving role of synthetic DNA in genetic medicine manufacturing and its potential applications across mRNA production, viral vectors, and gene editing.

Discover insights into:

  • Moving beyond plasmid DNA: Exploring the limitations of conventional DNA manufacturing and the potential advantages of cell-free synthetic DNA.

  • Supporting next-generation therapies: How synthetic DNA could support the development and manufacturing of mRNA therapies, viral vectors, and gene editing technologies.

  • Advancing DNA manufacturing: The importance of DNA quality and manufacturing approaches in enabling the next generation of genetic medicines.

Listen to the Podcast:

Explore how synthetic DNA could help address manufacturing challenges and support innovation across genetic medicines.

Next
Next

Precision at Scale: Optimizing Cell-Free DNA Manufacturing for Next-Generation mRNA Vaccines and Therapeutics